Pterygium: new insights.
Chu WK, Choi HL, Bhat AK, Jhanji V.
Eye (Lond). 2020 Jun;34(6):1047-1050. doi: 10.1038/s41433-020-0786-3. Epub 2020 Feb 6.
5-Fluorouracil in primary, impending recurrent and recurrent pterygium: Systematic review of the efficacy and safety of a surgical adjuvant and intralesional antimetabolite.
Lee BWH, Sidhu AS, Francis IC, Coroneo MT.
Ocul Surf. 2022 Oct;26:128-141. doi: 10.1016/j.jtos.2022.08.002. Epub 2022 Aug 9.
Dry-Eye Disease in Recurrent Pterygium.
Tan J, Vollmer-Conna U, Tat L, Coroneo M.
Ophthalmic Res. 2019;61(4):199-203. doi: 10.1159/000493544. Epub 2018 Oct 31.
Comparison of surgical techniques for recurrent pterygium.
Kim YJ, Rao R, Lee HJ.
Can J Ophthalmol. 2023 Oct;58(5):422-425. doi: 10.1016/j.jcjo.2022.05.011. Epub 2022 Jun 22.
Tear film cytokines as prognostic indicators for predicting early recurrent pterygium.
Wan Q, Wan P, Liu W, Cheng Y, Gu S, Shi Q, Su Y, Wang X, Liu C, Wang Z.
Exp Eye Res. 2022 Sep;222:109140. doi: 10.1016/j.exer.2022.109140. Epub 2022 Jun 6.
Management of primary and recurrent pterygium using amniotic membrane transplantation.
Ti SE, Tseng SC.
Curr Opin Ophthalmol. 2002 Aug;13(4):204-12. doi: 10.1097/00055735-200208000-00003.
Advanced recurrent pterygium leading to significant visual impairment.
Kurtul BE, Elbeyli A, Koca S.
Clin Exp Optom. 2020 Jul;103(4):544-545. doi: 10.1111/cxo.12949. Epub 2019 Aug 6.
Treatment of pterygium.
Mohammed I.
Ann Afr Med. 2011 Jul-Sep;10(3):197-203. doi: 10.4103/1596-3519.84695.
Ocular surface changes in recurrent pterygium cases post-operatively treated with 5-fluorouracil subconjunctival injections.
García Tirado A, Boto de Los Bueis A, Rivas Jara L.
Eur J Ophthalmol. 2019 Jan;29(1):9-14. doi: 10.1177/1120672118757428. Epub 2018 Mar 27.
Risk Factors for Recurrence in the Treatment of Recurrent Pterygium.
Kusano Y, Den S, Yamaguchi T, Nishisako S, Fukui M, Shimazaki J.
Cornea. 2024 Jun 1;43(6):740-745. doi: 10.1097/ICO.0000000000003422. Epub 2023 Nov 9.
